LI
Lite Strategy, Inc. (LITS)
NASDAQ·Healthcare·Biotechnology
$1.14
-2.56%
Mkt Cap $44.12M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 17, 2026 | — | — | — | — | -$0.82 | — | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | — | -$0.12 | — | — | — |
| Q3 2025 Sep 29, 2025 | — | — | — | — | -$0.40 | — | — | — |
| Q2 2025 May 13, 2025 | — | — | — | — | -$0.39 | — | — | — |
| Q4 2024 Dec 31, 2024 | — | — | — | -$2.20 | -$0.40 | +81.74% | — | — |
| Q3 2024 Sep 30, 2024 | — | — | — | -$1.70 | -$1.20 | +29.31% | — | — |
| Q2 2024 Jun 30, 2024 | — | — | — | -$1.41 | -$2.76 | -96.38% | — | — |
| Q1 2024 Mar 31, 2024 | $37.50K | — | — | -$1.49 | -$1.37 | +7.86% | — | — |
| Q4 2023 Dec 31, 2023 | $100.00K | — | — | -$1.41 | -$1.66 | -17.48% | — | — |
| Q4 2023 Nov 9, 2023 | — | $65.30M | — | -$1.79 | $8.46 | +571.31% | — | — |